Nifty
Sensex
:
:
24613.00
80716.55
26.30 (0.11%)
51.69 (0.06%)

Pharmaceuticals & Drugs

Rating :
33/99

BSE: 524572 | NSE: Not Listed

48.85
15-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  44.81
  •  48.86
  •  44.81
  •  46.54
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  5996
  •  285790
  •  79.23
  •  31.79

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 172.28
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 172.83
  • N/A
  • 2.42

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 5.64%
  • 4.54%
  • 41.06%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 48.76%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -100.00
  • -100.00
  • -100.00

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 36.83
  • 150.63
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 35.97
  • 111.18
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.84
  • 4.46
  • 4.46

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -10.46
  • -12.26
  • -12.26

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
5.81
0.00
0
0.02
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
11.38
8.60
32.33%
1.32
0.70
88.57%
1.02
0.54
88.89%
1.61
0.06
2,583.33%
EBITDA
-5.58
-8.60
-
-1.30
-0.70
-
-1.02
-0.54
-
-1.61
-0.06
-
EBIDTM
-96.09%
0.00%
-6,166.67%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.12
0.00
0
-0.90
0.00
-
-0.26
0.00
-
0.37
0.00
0
Interest
0.77
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.63
0.00
0
0.01
0.01
0.00%
0.01
0.01
0.00%
0.01
0.00
0
PBT
-6.86
-8.61
-
-2.21
-0.70
-
-1.29
-0.54
-
-1.24
-0.06
-
Tax
-0.53
-2.44
-
-0.58
0.00
-
-0.78
0.00
-
0.09
0.09
0.00%
PAT
-6.33
-6.16
-
-1.63
-0.71
-
-0.51
-0.55
-
-1.34
-0.14
-
PATM
-108.97%
0.00%
-7,780.95%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
-1.57
-2.87
-
-0.76
-0.69
-
-0.24
-0.53
-
-0.61
-0.14
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Net Sales
5.83
0.00
3.94
Net Sales Growth
0.00%
-100%
 
Cost Of Goods Sold
3.89
0.89
3.57
Gross Profit
1.94
-0.89
0.37
GP Margin
33.24%
0
9.39%
Total Expenditure
15.33
9.89
3.80
Power & Fuel Cost
-
0.00
0.00
% Of Sales
-
0
0%
Employee Cost
-
1.13
0.04
% Of Sales
-
0
1.02%
Manufacturing Exp.
-
0.00
0.00
% Of Sales
-
0
0%
General & Admin Exp.
-
0.84
0.18
% Of Sales
-
0
4.57%
Selling & Distn. Exp.
-
0.01
0.01
% Of Sales
-
0
0.25%
Miscellaneous Exp.
-
7.02
0.00
% Of Sales
-
0
0%
EBITDA
-9.51
-9.89
0.14
EBITDA Margin
-163.12%
0
3.55%
Other Income
-0.67
0.00
0.02
Interest
0.77
0.00
0.00
Depreciation
0.66
0.02
0.01
PBT
-11.60
-9.91
0.14
Tax
-1.80
-2.35
0.00
Tax Rate
15.52%
23.71%
0.00%
PAT
-9.81
-7.56
0.15
PAT before Minority Interest
-9.00
-7.56
0.15
Minority Interest
0.81
0.00
0.00
PAT Margin
-168.27%
0
3.81%
PAT Growth
0.00%
-
 
EPS
-2.78
-2.14
0.04

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Shareholder's Funds
22.46
8.67
Share Capital
21.44
10.27
Total Reserves
0.67
-1.60
Non-Current Liabilities
-2.71
-0.36
Secured Loans
0.00
0.00
Unsecured Loans
0.00
0.00
Long Term Provisions
0.00
0.00
Current Liabilities
2.13
2.44
Trade Payables
1.88
2.31
Other Current Liabilities
0.24
0.13
Short Term Borrowings
0.00
0.00
Short Term Provisions
0.00
0.00
Total Liabilities
21.88
10.75
Net Block
0.11
0.03
Gross Block
0.12
0.51
Accumulated Depreciation
0.02
0.48
Non Current Assets
4.25
8.09
Capital Work in Progress
2.00
0.45
Non Current Investment
0.00
0.00
Long Term Loans & Adv.
2.14
7.61
Other Non Current Assets
0.00
0.00
Current Assets
17.51
2.67
Current Investments
3.31
0.00
Inventories
0.00
0.89
Sundry Debtors
1.39
1.34
Cash & Bank
12.75
0.41
Other Current Assets
0.07
0.00
Short Term Loans & Adv.
0.07
0.03
Net Current Assets
15.39
0.23
Total Assets
21.88
10.76

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Cash From Operating Activity
-4.02
-0.26
PBT
-9.91
0.14
Adjustment
0.05
0.01
Changes in Working Capital
5.84
-0.41
Cash after chg. in Working capital
-4.01
-0.26
Interest Paid
0.00
0.00
Tax Paid
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
Extra & Other Items
0.00
0.00
Cash From Investing Activity
-4.94
0.47
Net Fixed Assets
-1.16
Net Investments
-3.27
Others
-0.51
Cash from Financing Activity
21.31
0.00
Net Cash Inflow / Outflow
12.35
0.21
Opening Cash & Equivalents
0.41
0.20
Closing Cash & Equivalent
12.75
0.41

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Book Value (Rs.)
10.26
8.44
ROA
-46.30%
1.35%
ROE
-49.28%
1.67%
ROCE
-63.87%
1.65%
Fixed Asset Turnover
0.00
7.75
Receivable days
0.00
124.04
Inventory Days
0.00
82.25
Payable days
861.23
235.65
Cash Conversion Cycle
-861.23
-29.36
Total Debt/Equity
0.00
0.00
Interest Cover
-2139.34
52.27

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.